Check Cap Ltd's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Check Cap Ltd in the fourth quarter 2025?
Check Cap Ltd achieved a return on average equity (ROE) of 117.66 % in its fourth quarter 2025, this is above CHEK's average return on equity of 74.67%.
Check Cap Ltd shareholder's equity over the 12 months ending in its fourth quarter 2025 are valued at $4 million

ROE fell compared to the third quarter 2025, despite the net income growth of % from the third quarter 2025.

Within the Medical Laboratories industry only one company had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from to 79.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Equity Change	-	-79.99 %	-84.11 %	-85.49 %	-
Y / Y Net Income Change	-76.43 %	-	-	-	-8.06 %
Net Income (TTM) in Millions	4	18	18	11	6
Return On Equity (TTM)	117.66 %	764.91 %	306.5 %	99.79 %	39.61 %
CHEK's Total Ranking	# 79	#	#	#	#
Equity (TTM) in Millions	3	3	4	3	-1
Seq. Equity Change	0 %	-8.66 %	9.49 %	-	-
Seq. Net Income Change	-	-	-	-	-

Back to CHEK Management Effectiveness >> CHEK's 5 Years Annual ROE >> Compare CHEK ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 2
Sector	# 16
Overall	# 79

Return On Equity Statistics
High	Average	Low
221.94 %	74.67 %	-74.17 %
(Dec 31 2019)		(Dec 31 2023)

CHEK Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	3	-1	24	41	51
Y / Y Equity Change	-	-	-42.66 %	-18.5 %	209.51 %
Net Income in Millions	4	-25	-18	-19	17
Y / Y Net Income Change	-	-	-	-	24.24 %
Return On Equity	120.45 %	-	-74.17 %	-46.25 %	33.94 %

Back to CHEK Management Effectiveness >> CHEK's 5 Years Annual ROE >> Compare CHEK ROE to its Competitors

Annual Roe Comment

In 2025 ROE fell to 120.45 %, despite net income growth.

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CHEK's' Return on Equity at Yahoo Finance
CHEK's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CHEK's Competitors
Subscribers only: Roe for Check Cap Ltd's Suppliers
Subscribers only: Return On Equity for CHEK's Customers

Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector	ROE
Traws Pharma inc	273.56 %
Scisparc Ltd	244.10 %
Rigel Pharmaceuticals Inc	240.83 %
Icecure Medical Ltd	166.36 %
Capforce Inc	157.18 %
Advanced Biomed Inc.	142.91 %
Check Cap Ltd	120.45 %
Medpace Holdings Inc	118.82 %
Tg Therapeutics Inc	101.12 %
Eli Lilly And Company	97.61 %
Amgen Inc	96.65 %
Halozyme Therapeutics Inc	92.67 %
Earth Science Tech Inc	82.09 %
Exelixis Inc	81.25 %
Elite Pharmaceuticals Inc	80.28 %
Zevra Therapeutics Inc	74.63 %
3m Company	71.32 %
Entera Bio Ltd	70.43 %
Aurinia Pharmaceuticals Inc	70.37 %
Idexx Laboratories Inc	69.78 %
Alnylam Pharmaceuticals Inc	69.25 %
Enlivex Therapeutics Ltd	63.85 %
Dariohealth Corp	59.48 %
Nrc Health	58.51 %
Zoetis Inc	56.31 %
Alpha Tau Medical Ltd	55.29 %
Transmedics Group Inc	53.88 %
Pulmatrix Inc	53.50 %
Abeona Therapeutics Inc	53.18 %
Medinotec Inc	52.76 %

Date modified: 2026-07-07T09:51:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.